Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07HBQ
|
||||
Former ID |
DNC008933
|
||||
Drug Name |
N,N,N-Triisobutyl-pyrimidine-2,4,6-triamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529687] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H31N5
|
||||
Canonical SMILES |
CC(C)CNC1=CC(=NC(=N1)NCC(C)C)NCC(C)C
|
||||
InChI |
1S/C16H31N5/c1-11(2)8-17-14-7-15(18-9-12(3)4)21-16(20-14)19-10-13(5)6/h7,11-13H,8-10H2,1-6H3,(H3,17,18,19,20,21)
|
||||
InChIKey |
HVZSNANIMUMCPH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [529687] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.